SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000812796-09-000020
Filing Date
2009-03-31
Accepted
2009-03-31 10:44:25
Documents
2
Period of Report
2009-03-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 DOR 8K ON FINANCIAL RESULTS 2008 dor8kfinancial2008.htm 8-K 22911
2 PRESS RELEASE ON FINANCIAL RESULTS pressrelease.htm EX-99.1 20604
  Complete submission text file 0000812796-09-000020.txt   45239
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-452-0001
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16929 | Film No.: 09716535
SIC: 2834 Pharmaceutical Preparations